Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
Jul 12, 2024
Jul 12, 2024
Jul 12, 2024
GMP
Manufacturing Operations
Supply Chain
Facilities Equipment
Quality
Jul 11, 2024
Jul 11, 2024
Jul 10, 2024